
STAT · Latest health and medicine news
20 entries · United States · Latest news
The source’s latest-news list, in its original order. Position does not measure popularity.
AvailableCollected:
- 1.STAT+: What are the health stakes of the midterms? Policymakers, lobbyists, and experts weigh inDaniel Payne · No matter what happens on Election Day, the midterms will have sweeping implications for American health care. More than two dozen experts on what could come next.
- 2.STAT+: Up and down the ladder: The latest comings and goingsEd Silverman · From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
- 3.How Election Day can affect your heartElizabeth Cooney · Political campaigns can do more than raise your blood pressure. Studies link election stress to irregular heartbeats and an increase in heart attacks.
- 4.Assessing Merck and Moderna’s mRNA cancer vaccineElaine Chen, Adam Feuerstein,and Allison DeAngelis · On this week's “The Readout LOUD,” we discuss the latest cancer data presented at the annual meeting of the European Society for Medical Oncology.
- 5.STAT+: Pharmalittle: We’re reading about AstraZeneca cost-cutting, Sun Pharma facility problems, and moreEd Silverman · AstraZeneca has launched a three-year cost-cutting program that aims to slice off $1.5 billion a year, with the savings reinvested in R&D.
- 6.The persisting paradox of men’s healthAnnalisa Merelli · A new series in The Lancet argues for the need to investigate a paradox of men’s health: why men experience worse health outcomes than women, even though they hold undeniable…
- 7.Opinion: What a mother’s 1834 letter about measles tells us about MAHAJim Downs · An 1834 letter about a measles outbreak sheds light on today’s anti-vaccine movement, writes a medical historian.
- 8.STAT+: FDA, CMS scramble to avoid regulatory logjam as more states look to test AI in clinical settingsMario Aguilar · Officials are moving behind the scenes to head off a conflict brewing between states and the federal government over regulating AI.
- 9.The health care issues STAT reporters are watching in the midtermsAlex Hogan · In this week's "STATus Report," STAT reporters break down how the midterms could shape federal health and science policy, and an El-Sayed interview.
- 10.Opinion: How Congress can fix expert advisory committeesC. Joseph Ross Daval and Aaron S. Kesselheim · “This evisceration of scientific advice is untenable,” write C. Joseph Ross Daval and Aaron S. Kesselheim.
- 11.STAT+: How a simple UTI turns into a $1,756 billTara Bannow · They visited for what they thought were obvious urgent care issues — coughs, congestion, flu — and were shocked to get bills for ER care instead, totaling thousands of dollars.
- 12.STAT+: Federal judge rejects new Medicaid ‘frailty’ definition for work requirementsO. Rose Broderick, Anil Oza,and Isabella Cueto · A judge ruled that federal regulators exceeded their authority in narrowing the exceptions to Medicaid work requirements for people with medical issues.
- 13.STAT+: New federal rule will require prescription drug middlemen to share secret payments dataBob Herman · A Trump administration rule will force pharmacy benefit managers to disclose fees and compensation details currently kept private.
- 14.STAT+: The EPIC investigation, and a Teladoc surpriseMario Aguilar · In this edition of STAT Health Tech: An Epic investigation, a Teladoc surprise, and figuring out how to pay for AI.
- 15.STAT+: Kennedy’s closing arguments for the 2026 midterms: Fraud, vaccines, and MAHAChelsea Cirruzzo · RFK Jr. is making his pitch ahead of a midterm election that could shape the fate of his MAHA movement.
- 16.STAT+: El-Sayed claps back at RFK Jr., and FDA’s ‘enforcement discretion’ on peptidesJohn Wilkerson · Abdul El-Sayed, the Democratic Senate candidate in Michigan, pushes back against the RFK Jr.'s claims, and the new FDA policy around peptides.
- 17.STAT+: HHS green lights six peptides, despite concerns from FDA scientistsMeghana Keshavan · Great news for peptide fans: The Trump administration is giving the peptide craze a regulatory boost, despite objections from FDA career scientists.
- 18.Martin Kulldorff critiques scientific gatekeepers at NIH lectureO. Rose Broderick and Nicholas Florko · Martin Kulldorff, the biostatistician who advocated against Covid lockdowns, insisted that the rise in measles cases is caused by a widely disputed claim about said lockdowns:
- 19.STAT+: Vertex kidney disease drug scrutinized for infection riskAdam Feuerstein · Ahead of its FDA approval decision on Nov 30, Vertex's kidney disease drug is being heavily scrutinized for infection risk.
- 20.STAT+: Pharmalittle: We’re reading about a new policy for compounding peptides, a PBM disclosure rule, and moreEd Silverman · HHS released a policy that will temporarily allow compounding pharmacies to manufacture some peptide products
About this list
Collection time is when WorldTopHub retrieved the list, not when its articles were published. Delayed updates may show the last available collection.
Each source keeps its latest successful ranking until a new collection replaces it. Check the collection time for freshness.